ArticleMolecular biology reports2025
Exome sequencing identifies novel genetic variants in patients with atypical Non-Syndromic retinitis pigmentosa.
Article in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRetinitis Pigmentosa is the leading cause of hereditary blindness. This clinically and genetically heterogeneous group of disorders typically begins with night blindness and progresses to complete vision loss. In atypical cases, the classic triad of retinal bone-spicule pigmentation, blood vessel attenuation, and waxy disc pallor is absent, complicating definitive clinical diagnosis.
methodsTo identify the underlying genetic causes in diagnostically challenging cases, exome sequencing was conducted on eight unrelated patients with atypical, non-syndromic Retinitis Pigmentosa. Putative causative variants were confirmed, and segregation analysis was performed in available families using Sanger sequencing.
resultsExome sequencing detected three novel pathogenic variants: MAK:c.768delA, RP1:c.4743delA, and RPE65:c.95-2 A > G. Furthermore, several known variants previously associated with atypical RP phenotypes were identified in our study, reinforcing their role in the disease and underscoring the critical value of genetic testing for a conclusive diagnosis.
conclusionsOur findings expand the mutational spectrum associated with Retinitis Pigmentosa, particularly in atypical cases. The identification of both novel and non-novel variants highlights the importance of Exome Sequencing in accurate diagnosis and possible personalized treatment.
Indexed as
Identifiers
41460542What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.